Form 4: Tandem Diabetes Care Director Rebecca Robertson Reports Stock Transactions

Director Rebecca Robertson reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

Summary

• On May 24, 2024, Rebecca Robertson, a director of Tandem Diabetes Care Inc., reported transactions involving the company's stock.
• Robertson acquired 4,434 shares of common stock through the vesting of restricted stock units at a price of $51.73 per share.
• Following these transactions, Robertson directly owns 9,396 shares of Tandem Diabetes Care stock.
• She also holds 4,387 restricted stock units, which were awarded on May 22, 2024, and will vest on the one-year anniversary of the grant date.
• Additionally, 4,434 restricted stock units awarded on May 24, 2023, vested.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock transactions by a company director, which is a routine occurrence.

Future Outlook

The restricted stock units awarded on May 22, 2024, will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the healthcare and medical device industry.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but it is unlikely to be significant.

Key Dates